ACTINOGEN MEDICAL LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.028 AUD | 0.00% |
|
-15.62% | +22.73% |
| 05-07 | Actinogen Medical Lodges Prospectus for Nearly AU$4 Million Entitlement Offer | MT |
| 05-03 | Actinogen Medical Raising Up to AU$8.9 Million for Advancing Trial, Working Capital; Shares Fall 24% | MT |
Chart calendar Actinogen Medical Limited
be41483bae4d75.zabmlm00ECWgpXBs1vpADwgTrhh-MFVM_cj3TcMIEdk.vsOSxhdjYUiV90kgv7dta1t3w345YmMUj47Of4xGdbu4wrfxPnxaS8nuAw~ee8bc1d70a655bfda3f28ee376eff482
Upcoming events on Actinogen Medical Limited
Past events on Actinogen Medical Limited
| 2024-03-26 | ASX Small and Mid Cap Conference |
| 2024-02-25 17:50 | Q2 2024 Earnings Release |
| 2024-01-07 | JPMorgan Healthcare Conference |
| 2024-01-06 | Sachs Neuroscience Innovation Forum |
| 2023-11-16 18:00 | Annual General Meeting |
| 2023-11-14 | Bell Potter Healthcare Conference |
| 2023-10-24 | CTAD Conference |
| 2023-10-16 | BIO Investor Forum |
| 2023-10-05 | Dementia Trials Australia Scientific Meeting |
| 2023-09-28 | Asian Society Against Dementia International Congress |
| 2023-08-30 21:00 | Business Update Call |
| 2023-08-30 05:04 | Q4 2023 Earnings Release |
| 2023-08-10 | Rights Issue: 100 new shares @ 0.025 AUD for 454 existing shares |
| 2023-07-30 21:39 | June 2023 Sales and Revenue Release - Activities Report |
| 2023-07-24 | Bioshares Biotech Summit |
| 2023-07-16 | Alzheimer Association International Conference |
| 2023-06-05 16:00 | BIO International Convention |
| 2023-05-23 21:00 | ACW Clinical Trials Science Forum |
| 2023-03-29 | Alzhelmer and Parkinson Diseases Conference |
| 2023-02-23 | Spark Plus Biotech Conference |
Annual results
| Fiscal Period | Juni | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million AUD | Released Forecast Spread | 4,86 | 3,61 3,00 20.35% | 0,00 | 3,68 2,50 47.25% | 5,25 4,42 18.83% | 7,70 |
|
EBITDA Million AUD | Released Forecast Spread | -9,05 | -4,89 -7,53 35.11% | 0,00 | -9,09 -7,11 -27.87% | -10,2 -9,00 -13.48% | -16,5 |
|
EBIT Million AUD | Released Forecast Spread | -9,40 | -5,30 -7,89 32.78% | 0,00 | -9,49 -7,51 -26.4% | -10,6 -9,40 -12.96% | -16,1 |
|
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | -9,89 | -5,33 -7,89 32.41% | 0,00 | -9,50 -7,51 -26.46% | -10,8 -9,40 -14.39% | -16,6 |
|
Net income Million AUD | Released Forecast Spread | -9,89 | -5,33 -7,89 32.41% | -3,92 | -9,50 -7,51 -26.46% | -10,8 -9,40 -14.39% | -16,6 |
|
EPS AUD | Released Forecast Spread | -0,01 | 0,00 -0,01 32.43% | 0,00 | -0,01 -0,01 9.67% | -0,01 -0,01 -18.4% | -0,01 |
| Announcement Date | 16/08/19 | 26/08/20 | 30/08/21 | 25/08/22 | 30/08/23 | - |
Quarterly results
| Fiscal Period | Juni | 2023 S1 |
|---|---|---|
|
Net sales Million AUD | Released Forecast Spread | 1,14 0,00 - |
|
EBIT Million AUD | Released Forecast Spread | -7,34 -7,00 -4.93% |
|
Net income Million AUD | Released Forecast Spread | -7,44 -7,00 -6.27% |
| Announcement Date | 22/02/23 |
| 2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 2024-05-15 | REPLIMUNE GROUP, INC.: Q4 2024 Earnings Release (Projected) |
| 2024-05-17 02:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
| 2024-05-20 | ALVOTECH: Q1 2024 Earnings Release |
| 2024-05-21 | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
| 2024-05-21 | EXSCIENTIA PLC: Q1 2024 Earnings Release (Projected) |
| 2024-05-21 | EVOTEC SE: Q1 2024 Earnings Release |
| 2024-06-30 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
| 2024-07-15 01:45 | ADDLIFE AB: Q2 2024 Earnings Release |
| 2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Actinogen Medical Limited
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ACW Stock
- Calendar Actinogen Medical Limited
